MedTrace Logo

RSV Burden in Outpatient and Hospital Settings

NCT04743609 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1900

Last updated 2026-03-19

No results posted yet for this study

Summary

Strengthening outpatient low respiratory tract infection surveillance to document the burden of Respiratory Syncytial Virus (RSV)

Conditions

  • RSV Infection
  • Children, Only
  • Outpatient
  • Otitis

Interventions

DIAGNOSTIC_TEST

nasopharyngeal samples

rapid antigen test for Sars Cov-2, influenza and RSV.

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Association Clinique Thérapeutique Infantile du val de Marne

    lead OTHER

Principal Investigators

  • Robert Cohen · Association Clinique et Thérapeutique Infantile du Val de Marne

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Day
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-08
Primary Completion
2026-12-08
Completion
2026-12-08

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04743609 on ClinicalTrials.gov